This topic contains a solution. Click here to go to the answer

Author Question: A patient has chosen to receive palliative care after his lung cancer metastasized to his bones and ... (Read 96 times)

lindiwe

  • Hero Member
  • *****
  • Posts: 577
A patient has chosen to receive palliative care after his lung cancer metastasized to his bones and liver. Which of the following is most appropriate during palliative cancer care?
 
  A) Abrupt cessation of chemotherapy immediately prior to entering palliative care
  B) Aggressive chemotherapy to reduce malignant cell proliferation
  C) The use of chemotherapy to reduce pain
  D) The replacement of chemotherapy with complementary and alternative treatments

Question 2

A patient is diagnosed with cardiogenic shock. The patient is administered milrinone (Primacor). What effect is produced by this medication?
 
  A) Increase vascular resistance
  B) Increase cardiac output
  C) Increase heart rate
  D) Decrease urine output



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bigfoot1984

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

C
Feedback:
Palliative chemotherapy is used in advanced cancer to prevent or treat pain and obstruction. Chemotherapy does not need to be stopped abruptly or replaced with CAM. Aggressive chemotherapy would not normally be administered in a palliative context.

Answer to Question 2

B




lindiwe

  • Member
  • Posts: 577
Reply 2 on: Jul 23, 2018
Excellent


LVPMS

  • Member
  • Posts: 323
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library